BioCentury | Apr 14, 2021
Deals

April 13 Quick Takes: Mega-rounds for Flagship's Repertoire, Arcellx, GH, Theseus; plus Biophytis, Resilience, Cerevel, C4X, Sanofi and more

...Capital, Suvretta, and Terra Magnum Capital Partners, joined existing investors NEA, Novo Holdings, SR One, Takeda...
BioCentury | Apr 13, 2021
Deals

Sanofi joins in vivo cell engineering wave, snapping up stealthy Fred Hutch mRNA delivery spinout

...cellular immunotherapies by engineering cells in vivo include Ensoma, which launched in February with a Takeda Pharmaceutical Co. Ltd....
BioCentury | Apr 7, 2021
Management Tracks

Takeda’s Koo to lead Overland-ADC joint venture; plus Precision, Amryt, Bridge, Opthea and Cogent

...MNCs, most recently Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK), where he was VP, head of oncology business unit at Takeda...
BioCentury | Apr 7, 2021
Product Development

April 6 Quick Takes: MGH to pilot AZ digital platform; plus NorthShore-GoPath prostate cancer risk test, baricitinib delay at FDA, MTEM setback

...10% to $8.61 Tuesday after Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) turned over full rights to TAK-169. MTEM said Takeda’s...
BioCentury | Apr 6, 2021
Finance

VCs led by HBM, Samsara back single-asset Mitsubishi Tanabe spinout Mineralys with $40M for hypertension program

...portfolio also includes Phathom Pharmaceuticals Inc. (NASDAQ:PHAT), which holds territorial rights to gastrointestinal drug vonoprazan from Takeda Pharmaceutical Co. Ltd....
BioCentury | Apr 3, 2021
Product Development

Target diversity in the CAR NK and CAR NKT pipeline: Data Byte

...less risk of graft-versus-host disease.Early clinical data for TAK-007, a CD19-directed CAR NK cell from Takeda Pharmaceutical Co. Ltd....
...subfamily K member 1PD-L1 (B7-H1; CD274) – Programmed cell death 1 ligand 1 Sandi Wong TAK-007 KUR-501, CMD-501 KUR-502, CMD-502 Kuur Therapeutics Takeda Pharmaceutical Co. Ltd. ImmunityBio...
BioCentury | Mar 30, 2021
Deals

Deerfield’s growing umbrella: Data Byte

...that follow a slightly different model. In 2016, Deerfield backed drug discovery play Bridge Medicines alongside Takeda Pharmaceutical Co. Ltd....
BioCentury | Mar 27, 2021
Product Development

What it will take to meet CEPI’s 100-day vaccine goal for the next pandemic

...president of the Global Vaccine Business Unit at Takeda Pharmaceutical Co. Ltd....
...doesn’t work for certain targets.” Rajeev Venkayya, Takeda...
...platforms all over the world.” Rajeev Venkayya, Takeda...
BioCentury | Mar 24, 2021
Finance

With cancer foot forward, Step making strides toward clinic with €35M series B

...disclosed a preclinical CTPS1 program. Parker believes Step is “a couple of years ahead” of Nimbus.Takeda Pharmaceutical Co. Ltd....
BioCentury | Mar 23, 2021
Product Development

March 22 Quick Takes: Ionis falls as Genentech halts Huntington’s trial; plus Pfizer, Evotec-Takeda, Everest, BioCryst and Odonate

...risk of joint destruction.Evotec, Takeda enter RNA targeting dealEvotec SE (Xetra:EVT) entered a collaboration with Takeda Pharmaceutical Co. Ltd....
Items per page:
1 - 10 of 3843
BioCentury | Apr 14, 2021
Deals

April 13 Quick Takes: Mega-rounds for Flagship's Repertoire, Arcellx, GH, Theseus; plus Biophytis, Resilience, Cerevel, C4X, Sanofi and more

...Capital, Suvretta, and Terra Magnum Capital Partners, joined existing investors NEA, Novo Holdings, SR One, Takeda...
BioCentury | Apr 13, 2021
Deals

Sanofi joins in vivo cell engineering wave, snapping up stealthy Fred Hutch mRNA delivery spinout

...cellular immunotherapies by engineering cells in vivo include Ensoma, which launched in February with a Takeda Pharmaceutical Co. Ltd....
BioCentury | Apr 7, 2021
Management Tracks

Takeda’s Koo to lead Overland-ADC joint venture; plus Precision, Amryt, Bridge, Opthea and Cogent

...MNCs, most recently Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK), where he was VP, head of oncology business unit at Takeda...
BioCentury | Apr 7, 2021
Product Development

April 6 Quick Takes: MGH to pilot AZ digital platform; plus NorthShore-GoPath prostate cancer risk test, baricitinib delay at FDA, MTEM setback

...10% to $8.61 Tuesday after Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) turned over full rights to TAK-169. MTEM said Takeda’s...
BioCentury | Apr 6, 2021
Finance

VCs led by HBM, Samsara back single-asset Mitsubishi Tanabe spinout Mineralys with $40M for hypertension program

...portfolio also includes Phathom Pharmaceuticals Inc. (NASDAQ:PHAT), which holds territorial rights to gastrointestinal drug vonoprazan from Takeda Pharmaceutical Co. Ltd....
BioCentury | Apr 3, 2021
Product Development

Target diversity in the CAR NK and CAR NKT pipeline: Data Byte

...less risk of graft-versus-host disease.Early clinical data for TAK-007, a CD19-directed CAR NK cell from Takeda Pharmaceutical Co. Ltd....
...subfamily K member 1PD-L1 (B7-H1; CD274) – Programmed cell death 1 ligand 1 Sandi Wong TAK-007 KUR-501, CMD-501 KUR-502, CMD-502 Kuur Therapeutics Takeda Pharmaceutical Co. Ltd. ImmunityBio...
BioCentury | Mar 30, 2021
Deals

Deerfield’s growing umbrella: Data Byte

...that follow a slightly different model. In 2016, Deerfield backed drug discovery play Bridge Medicines alongside Takeda Pharmaceutical Co. Ltd....
BioCentury | Mar 27, 2021
Product Development

What it will take to meet CEPI’s 100-day vaccine goal for the next pandemic

...president of the Global Vaccine Business Unit at Takeda Pharmaceutical Co. Ltd....
...doesn’t work for certain targets.” Rajeev Venkayya, Takeda...
...platforms all over the world.” Rajeev Venkayya, Takeda...
BioCentury | Mar 24, 2021
Finance

With cancer foot forward, Step making strides toward clinic with €35M series B

...disclosed a preclinical CTPS1 program. Parker believes Step is “a couple of years ahead” of Nimbus.Takeda Pharmaceutical Co. Ltd....
BioCentury | Mar 23, 2021
Product Development

March 22 Quick Takes: Ionis falls as Genentech halts Huntington’s trial; plus Pfizer, Evotec-Takeda, Everest, BioCryst and Odonate

...risk of joint destruction.Evotec, Takeda enter RNA targeting dealEvotec SE (Xetra:EVT) entered a collaboration with Takeda Pharmaceutical Co. Ltd....
Items per page:
1 - 10 of 3843